These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7919133)

  • 1. Consequences of acute nitric oxide synthesis inhibition in experimental glomerulonephritis.
    Ferrario R; Takahashi K; Fogo A; Badr KF; Munger KA
    J Am Soc Nephrol; 1994 May; 4(11):1847-54. PubMed ID: 7919133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat.
    Takahashi K; Schreiner GF; Yamashita K; Christman BW; Blair I; Badr KF
    J Clin Invest; 1990 Jun; 85(6):1974-82. PubMed ID: 2347921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute nitric oxide inhibition on rat glomerular microcirculation.
    Zatz R; de Nucci G
    Am J Physiol; 1991 Aug; 261(2 Pt 2):F360-3. PubMed ID: 1877654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
    Qiu C; Baylis C
    Kidney Int; 1999 Jun; 55(6):2390-6. PubMed ID: 10354287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1995 Aug; 26(2):249-55. PubMed ID: 7543452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist.
    Badr KF; Schreiner GF; Wasserman M; Ichikawa I
    J Clin Invest; 1988 Jun; 81(6):1702-9. PubMed ID: 3384947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient.
    Deng A; Baylis C
    Am J Physiol; 1993 Feb; 264(2 Pt 2):F212-5. PubMed ID: 8447434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors.
    Edwards RM; Trizna W
    J Am Soc Nephrol; 1993 Nov; 4(5):1127-32. PubMed ID: 7508276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity.
    Bobadilla NA; Tapia E; Franco M; López P; Mendoza S; García-Torres R; Alvarado JA; Herrera-Acosta J
    Kidney Int; 1994 Sep; 46(3):773-9. PubMed ID: 7996799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of glomerular filtration in experimental glomerulonephritis in the rat.
    Maddox DA; Bennett CM; Deen WM; Glassock RJ; Knutson D; Daugharty TM; Brenner BM
    J Clin Invest; 1975 Feb; 55(2):305-18. PubMed ID: 1127101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis.
    Narita I; Border WA; Ketteler M; Noble NA
    Lab Invest; 1995 Jan; 72(1):17-24. PubMed ID: 7837786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion pressure and volume status determine the microvascular response of the rat kidney to NG-monomethyl-L-arginine.
    Lockhart JC; Larson TS; Knox FG
    Circ Res; 1994 Nov; 75(5):829-35. PubMed ID: 7923628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock.
    Lieberthal W; McGarry AE; Sheils J; Valeri CR
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F868-72. PubMed ID: 1951718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.
    Polichnowski AJ; Licea-Vargas H; Picken M; Long J; Bisla R; Williamson GA; Bidani AK; Griffin KA
    Am J Physiol Renal Physiol; 2015 Nov; 309(9):F791-9. PubMed ID: 26109088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular and tubular interactions between renal adrenergic activity and nitric oxide.
    Gabbai FB; Thomson SC; Peterson O; Wead L; Malvey K; Blantz RC
    Am J Physiol; 1995 Jun; 268(6 Pt 2):F1004-8. PubMed ID: 7611442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis; effects of selective inhibition in neutrophil-dependent glomerulonephritis.
    Waddington SN; Mosley K; Cattell V
    Clin Exp Immunol; 1999 Nov; 118(2):309-14. PubMed ID: 10540196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide: a potential mediator of amino acid-induced renal hyperemia and hyperfiltration.
    King AJ; Troy JL; Anderson S; Neuringer JR; Gunning M; Brenner BM
    J Am Soc Nephrol; 1991 Jun; 1(12):1271-7. PubMed ID: 1912389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
    Ribeiro MO; Antunes E; de Nucci G; Lovisolo SM; Zatz R
    Hypertension; 1992 Sep; 20(3):298-303. PubMed ID: 1516948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Arginine supplementation increases mesangial cell injury and subsequent tissue fibrosis in experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 1999 Jun; 55(6):2264-73. PubMed ID: 10354274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.